This seminar describes the lessons learned from a deep-dive workshop about how to adapt to the Inflation Reduction Act's measures to control drug prices in the US, but it is equally relevant for any pharma or medtech company trying to influence market access or reimbursement policy.

I’d welcome comments and if you find this useful, please share it with your colleagues.

If you would like to read the article on which this seminar is based, you can request at www.pragmedic.com (my latest publications). If you would like to browse over 300 articles about the evolution of business models and strategy in the life sciences industry, take a look at www.pragmedic.com, my published work. If you'd like to follow my research in this area, follow at LinkedIn (@drbriandsmith) and Twitter (@profbriandsmith) If, like me, you're fascinated by our industry and would like to set up an informal, virtual chat with me then get in touch through www.pragmedc.com.And of course I'd love it if you shared, liked and subscribed to both my Darwin's Medicine podcast and my YouTube channel.